Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis.

Chen, Yung-Yi; Jeffery, Hannah C; Hunter, Stuart; Bhogal, Ricky; Birtwistle, Jane; Braitch, Manjit Kaur; Roberts, Sheree; Ming, Mikaela; Hannah, Jack; Thomas, Clare; Adali, Gupse; Hübscher, Stefan G; Syn, Wing-Kin; Afford, Simon; Lalor, Patricia F; Adams, David H; Oo, Ye H

Chen, Yung-Yi; Jeffery, Hannah C; Hunter, Stuart; Bhogal, Ricky; Birtwistle, Jane; Braitch, Manjit Kaur; Roberts, Sheree; Ming, Mikaela; Hannah, Jack; Thomas, Clare; Adali, Gupse; Hübscher, Stefan G; Syn, Wing-Kin; Afford, Simon; Lalor, Patricia F; Adams, David H; Oo, Ye H.

Affiliation

Chen YY; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Jeffery HC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Hunter S; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Bhogal R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Birtwistle J; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Braitch MK; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Roberts S; Clinical Immunology Department, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Ming M; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Hannah J; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Thomas C; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Adali G; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Hübscher SG; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Syn WK; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
Afford S; Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham, United Kingdom.
Lalor PF; The Institute of Hepatology, London, United Kingdom.
Adams DH; Division of Gastroenterology and Hepatology, The Medical University of South Carolina, Charleston, South Carolina, USA.
Oo YH; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.

Hepatology ; 64(1): 138-50, 2016 07.

Article de En | MEDLINE | ID: mdl-26928938

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Interleukine-2 / Lymphocytes T régulateurs / Maladies du foie Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Hepatology Année: 2016 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google